STRATEGY STUDIO / NONPROFIT PEOPLE SEARCH

FRIEDREICHS ATAXIA RESEARCH ALLIANCE FARA: Form 990, tax year 2012

View the entire original 990 at ProPublica ↗

Organization
FRIEDREICHS ATAXIA RESEARCH ALLIANCE FARA (EIN 52-2122720)
Tax period
2012-01-01 to 2012-12-31
Filed
2013-05-03
IRS object ID
201341239349301059
Schema version
2012v2.1
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Timestamp2013-05-03T14:50:22-05:00Timestamp
Tax Period End Date2012-12-31TaxPeriodEndDate

Preparer Firm PreparerFirm

FieldValueIRS element (for citing)
EIN231518888EIN

Preparer Firm Business Name PreparerFirmBusinessName

FieldValueIRS element (for citing)
Business Name Line1MAILLIE FALCONIERO & COMPANY LLPBusinessNameLine1

Preparer Firm US Address PreparerFirmUSAddress

FieldValueIRS element (for citing)
Address Line1PO BOX 3068AddressLine1
CityWEST CHESTERCity
StatePAState
ZIP Code193813068ZIPCode
FieldValueIRS element (for citing)
Return Type990ReturnType
Tax Period Begin Date2012-01-01TaxPeriodBeginDate

Filer Filer

FieldValueIRS element (for citing)
EIN522122720EIN

Name Name

FieldValueIRS element (for citing)
Business Name Line1FRIEDREICH'S ATAXIA RESEARCH ALLIANCEBusinessNameLine1
FieldValueIRS element (for citing)
Name ControlFRIENameControl
Phone4848796160Phone

US Address USAddress

FieldValueIRS element (for citing)
Address Line1PO BOX 1537AddressLine1
CitySPRINGFIELDCity
StateVAState
ZIP Code22151ZIPCode

Officer Officer

FieldValueIRS element (for citing)
NameJENNIFER FARMERName
TitleEXECUTIVE DIRECTORTitle
Phone4848796160Phone
Date Signed2013-04-17DateSigned
Authorize Third Party1AuthorizeThirdParty

Preparer Preparer

FieldValueIRS element (for citing)
NameEDWARD FRONCZKOWSKI CPAName
PTINP01259092PTIN
Phone6106964353Phone
FieldValueIRS element (for citing)
Tax Year2012TaxYear
Build TS2016-03-07 17:11:31ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Name Of Principal Officer PersonJENNIFER FARMERNameOfPrincipalOfficerPerson

Address Principal Officer US AddressPrincipalOfficerUS

FieldValueIRS element (for citing)
Address Line1533 W UWCHLAN AVENUEAddressLine1
CityDOWNINGTOWNCity
StatePAState
ZIP Code19335ZIPCode
FieldValueIRS element (for citing)
Gross Receipts3846571GrossReceipts
Group Return For Affiliates0GroupReturnForAffiliates
Organization501c3XOrganization501c3
Web SiteWWW.CUREFA.ORGWebSite
Type Of Organization CorporationXTypeOfOrganizationCorporation
Year Formation1998YearFormation
State Legal DomicileVAStateLegalDomicile
Activity Or Mission DescriptionTO TREAT AND CURE FRIEDREICH'S ATAXIA BY ADVANCING RESEARCH, AWARENESS AND PARTNERSHIPS.ActivityOrMissionDescription
Nbr Voting Members Governing Body16NbrVotingMembersGoverningBody
Nbr Independent Voting Members15NbrIndependentVotingMembers
Total Nbr Employees6TotalNbrEmployees
Total Nbr Volunteers350TotalNbrVolunteers
Total Gross UBI0TotalGrossUBI
Net Unrelated Business Txbl Income0NetUnrelatedBusinessTxblIncome
Contributions Grants Prior Year2831171ContributionsGrantsPriorYear
Contributions Grants Current Year3174652ContributionsGrantsCurrentYear
Program Service Revenue Prior Year0ProgramServiceRevenuePriorYear
Program Service Revenue CY0ProgramServiceRevenueCY
Investment Income Prior Year12704InvestmentIncomePriorYear
Investment Income Current Year21555InvestmentIncomeCurrentYear
Other Revenue Prior Year133726OtherRevenuePriorYear
Other Revenue Current Year127578OtherRevenueCurrentYear
Total Revenue Prior Year2977601TotalRevenuePriorYear
Total Revenue Current Year3323785TotalRevenueCurrentYear
Grants And Similar Amnts Prior Year2484153GrantsAndSimilarAmntsPriorYear
Grants And Similar Amnts CY2673157GrantsAndSimilarAmntsCY
Benefits Paid To Members Prior Year0BenefitsPaidToMembersPriorYear
Benefits Paid To Members CY0BenefitsPaidToMembersCY
Salaries Etc Prior Year359219SalariesEtcPriorYear
Salaries Etc Current Year420293SalariesEtcCurrentYear
Total Prof Fundrsng Exp Prior Year0TotalProfFundrsngExpPriorYear
Total Prof Fundrsng Exp CY0TotalProfFundrsngExpCY
Total Fundrsng Exp Current Year149523TotalFundrsngExpCurrentYear
Other Expense Prior Year200872OtherExpensePriorYear
Other Expenses Current Year167762OtherExpensesCurrentYear
Total Expenses Prior Year3044244TotalExpensesPriorYear
Total Expenses Current Year3261212TotalExpensesCurrentYear
Revenues Less Expenses Prior Year-66643RevenuesLessExpensesPriorYear
Revenues Less Expenses CY62573RevenuesLessExpensesCY
Total Assets BOY2783758TotalAssetsBOY
Total Assets EOY3032470TotalAssetsEOY
Total Liabilities BOY170510TotalLiabilitiesBOY
Total Liabilities EOY264360TotalLiabilitiesEOY
Net Assets Or Fund Balances BOY2613248NetAssetsOrFundBalancesBOY
Net Assets Or Fund Balances EOY2768110NetAssetsOrFundBalancesEOY
Info In Schedule O Part IIIXInfoInScheduleOPartIII
Mission DescriptionTO MARSHAL AND FOCUS THE RESOURCES AND RELATIONSHIPS NEEDED TO CURE FA BY RAISING FUNDS FOR RESEARCH, PROMOTING PUBLIC AWARENESS AND ALIGNING SCIENTISTS, PATIENTS, CLINICIANS, GOV'T AGENCIES AND PHARMACEUTICAL COMPANIES DEDICATED TO CURING FA AND RELATED DISORDERS.MissionDescription
Significant New Program Services0SignificantNewProgramServices
Significant Change0SignificantChange
Expense2835082Expense
Grants2673157Grants
DescriptionRESEARCH & GRANT PROGRAM: FARA'S COMMITMENT TO FUNDING HIGH QUALITY RESEARCH PROJECTS THAT MOVE US CLOSER TO EFFECTIVE TREATMENTS CONTINUED AT AN ACCELERATED PACE IN 2012. IN TOTAL, FARA PROVIDED >$2.6M IN BASIC AND TRANSLATIONAL AND CLINICAL RESEARCH GRANTS, SCIENTIFIC CONFERENCE SUPPORT AND CLINICAL RESEARCH INFRASTRUCTURE FUNDING. OVER THE PAST YEAR, >25 NEW GRANT APPLICATIONS WERE SUBMITTED AND AFTER RIGOROUS PEER REVIEW, 17 WERE DETERMINED MERITORIOUS AND AWARDED FUNDING IN 2012 AND EARLY 2013. IN ADDITION, BASED ON EXCELLENT PROGRESS, CONTINUATION FUNDING WAS PROVIDED FOR 9 PROJECTS, FOR A TOTAL OF 26 RESEARCH GRANTS AWARDED. FARA ALSO AWARDED TWO CONFERENCE GRANTS TO SUPPORT SCIENTIFIC MEETINGS WITH CONTENT FOCUSED ON FRIEDREICH'S ATAXIA. THESE FUNDED PROJECTS ADDRESS NUMEROUS IMPORTANT RESEARCH QUESTIONS THAT DIRECTLY TARGET FARA'S STRATEGIC RESEARCH INITIATIVES, INCLUDING DRUG DISCOVERY, PRE-CLINICAL AND CLINICAL STUDIES OF LEAD CANDIDATES IN THE TREATMENT PIPELINE, ADVANCES IN GENE AND CELL THERAPY APPROACHES, ADVANCES IN DIFFERENTIATION OF INDUCED PLURIPOTENT STEM (IPS) CELL LINES FROM FA PATIENTS INTO SENSORY NEURONS AND CARDIOMYOCYTES, DEVELOPMENT OF NEW ANIMAL MODELS, CARDIAC RESEARCH AND EVALUATION OF NOVEL BIOMARKERS. SEVERAL ARE CO-FUNDED WITH OUR FRIEDREICH'S ATAXIA ADVOCACY GROUP PARTNERS; THIS COLLABORATIVE APPROACH BOTH INCREASES THE NUMBER OF AVAILABLE RESEARCH DOLLARS AND HELPS TO MINIMIZE DUPLICATION OF EFFORT. OF NOTE, FA SHARES SIMILAR SYMPTOMS AND DISEASE MECHANISMS WITH OTHER DISEASES, BOTH RARE AND COMMON. RESEARCH INTO FA IS PROVIDING INSIGHTS AND ADVANCES IN OTHER DISEASES SUCH AS MITOCHONDRIAL DISEASES, MUSCULAR DYSTROPHIES, DIABETES, AND CARDIOMYOPATHY. A SAMPLE OF 2012 FARA FUNDED GRANTS FOLLOWS BELOW: - NEW INVESTIGATOR AWARD: DR. VIJAYENDRAN CHANDRAN, UNIVERSITY OF CALIFORNIA LOS ANGELESA SENIOR POSTDOCTORAL FELLOW WITH DR. DANIEL GESCHWIND AT UCLA, DR CHANDRAN IS DEVELOPING AN INDUCIBLE MOUSE MODEL OF FA SUCH THAT FRATAXIN LEVELS CAN BE REDUCED AND RESTORED. THIS MODEL HAS THE POTENTIAL TO COMPLEMENT AND EXTEND THE CAPABILITIES OF EXISTING FA MOUSE MODELS FOR ADVANCING OUR UNDERSTANDING OF THE PATHOGENESIS OF FA AND THE FUNCTION OF FRATAXIN, AS WELL AS FOR TESTING PROMISING THERAPEUTIC AGENTS. - KEITH MICHAEL ANDRUS MEMORIAL AWARD (FOR CARDIAC RESEARCH): DR. FRANCESCO SACCA, UNIVERSITY FEDERICO II OF NAPLES, ITALYDR. SACCA, TOGETHER WITH DR. ALESSANDRO FILLA, IS CONDUCTING A PHASE II CLINICAL TRIAL TO TEST THE EFFICACY OF EPO ON EXERCISE CAPACITY IN PATIENTS WITH FA. IN THIS RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, EPO IS BEING ADMINISTERED EVERY 12 WEEKS FOR A TOTAL DURATION OF 48 WEEKS. IN ADDITION TO EXERCISE CAPACITY, THE CLINICAL PROTOCOL ALSO INCLUDES MONITORING OF FRATAXIN LEVELS, CARDIOMYOPATHY, VASCULAR REACTIVITY, CLINICAL PROGRESSION, AND SAFETY. - DRUG DISCOVERY PROJECT AT STATEGICS INC., MENLO PARK, CA (PRINCIPAL INVESTIGATOR: DR. JUHA PUNNONEN)THIS STUDY IS EVALUATING IMPROVED EPO MIMETICS IN FA CELL AND MOUSE MODELS TO FOLLOW UP ON PREVIOUS FINDINGS THAT THESE COMPOUNDS INCREASE FRATAXIN LEVELS. THE GOAL IS TO IDENTIFY AN OPTIMAL THERAPEUTIC CANDIDATE TO ADVANCE TO CLINICAL TRIAL. - PRE-CLINICAL DEVELOPMENT OF HDAC INHIBITORS AT REPLIGEN CORPORATION, WALTHAM, MA(PRINCIPAL INVESTIGATOR: DR. JAMES RUSCHE)THIS STUDY WILL COMPLETE A THOROUGH EVALUATION OF A FOLLOW-ON HDACI CANDIDATE (RGFP963/RG3250) TO THE HDAC INHIBITOR, RG2833, FOR WHICH A PHASE I CLINICAL TRIAL IS TAKING PLACE IN ITALY. THE FOLLOW-ON CANDIDATE HAS SOME SPECIFIC QUALITIES THAT WILL LIKELY MAKE IT A BETTER CLINICAL CANDIDATE, E.G., CROSSING THE BLOOD BRAIN BARRIER BETTER (BETTER PENETRATION TO THE NERVOUS SYSTEM) AND METABOLIC STABILITY. - THERAPEUTIC COMPOUND IDENTIFICATION BY DR. MAREK NAPIERALA , UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER, HOUSTONDR. NAPIERALA RECEIVED FUNDING TO CHARACTERIZE POTENTIALLY THERAPEUTIC COMPOUNDS IDENTIFIED USING A HIGH THROUGHPUT SCREENING (HTS) ASSAY THAT DETECTS COMPOUNDS CAPABLE OF ALLEVIATING GAA REPEAT-INDUCED SILENCING. USING DR. NAPIERALA'S ASSAY, HTS OF 360,000 COMPOUNDS WAS CARRIED OUT THROUGH THE NIH MOLECULAR LIBRARIES SCREENING CENTERS NETWORK; HE IS NOW EVALUATING SEVERAL PROMISING HITS FOR THEIR EFFECT ON FRATAXIN EXPRESSION IN FA FIBROBLASTS AND NEURONAL CELLS DIFFERENTIATED FROM INDUCED PLURIPOTENT STEM CELLS. - ADDITIONALLY, FARA CONTINUES TO SUPPORT THE STANDARDIZED CHARACTERIZATION OF FRDA MOUSE MODELS AT THE JACKSON LABORATORY. IN ADDITION TO RESEARCH GRANTS, FARA FUNDS THE ONGOING DEVELOPMENT OF VITAL CLINICAL RESEARCH INFRASTRUCTURE. CLINICAL RESEARCH INFRASTRUCTURE REFERS TO THE RESOURCES NEEDED TO FACILITATE ANY TYPE OF RESEARCH, INCLUDING CLINICAL TRIALS THAT INVOLVE PATIENTS. THESE RESOURCES CAN INCLUDE THINGS LIKE: - PATIENT REGISTRY : FARA MANAGES THE ONLY INTERNATIONAL FRIEDREICH ATAXIA PATIENT REGISTRY WITH MORE THAN 2000 INDIVIDUALS ENROLLED. THIS REGISTRY CAPTURES DEMOGRAPHIC AND CLINICAL INFORMATION ON INDIVIDUALS WITH FA AND IS USED TO RECRUIT INDIVIDUALS FOR CLINICAL TRIALS WORLD WIDE.FARA PATIENT REGISTRY : WWW.CUREFA.ORG/REGISTRY - COLLABORATIVE CLINICAL RESEARCH NETWORK IN FA (CCRN IN FA): AN INTERNATIONAL NETWORK OF 10 CLINICAL RESEARCH CENTERS THAT WORK TOGETHER TO ADVANCE TREATMENTS AND CLINICAL CARE FOR INDIVIDUALS WITH FRIEDREICH'S ATAXIA. HAVING SUCH A NETWORK MEANS THAT THERE ARE TRAINED PHYSICIANS AND RESEARCH COORDINATORS READY TO DO CLINICAL RESEARCH STUDIES AND TRIALS. ALSO, THIS NETWORK IS BACKED BY A DATA COORDINATION CENTER THAT FACILITATES ALL ASPECTS OF DATA COLLECTION, DATABASE MANAGEMENT, AND STATISTICAL ANALYSIS OF STUDY DATA. TO LEARN MORE, VISIT WWW.CUREFA.ORG/NETWORK.HTML - NATURAL HISTORY STUDY: LONGITUDINAL DATA (USUALLY ABOUT 10 YEARS) ON INDIVIDUALS WITH A DISEASE THAT DESCRIBES AND QUANTIFIES THE PROGRESSION OF THE DISEASE ALONG WITH THE SYMPTOMS AND MANIFESTATIONS OF THE DISEASE. NATURAL HISTORY CAN SOMETIMES SERVE AS THE BASIS FROM WHICH MEASUREMENTS CAN BE MADE TO DETERMINE EFFECTS OF NEW TREATMENTS, DRUGS OR INTERVENTIONS. - CLINICAL OUTCOME MEASURES : FUNCTIONAL PERFORMANCE TESTS (E.G., TIMED PEGBOARD OR WALK TESTS, VISION, HEARING OR SPEECH TESTS) THAT QUANTIFY HOW MUCH CHANGE TAKES PLACE IN A SPECIFIC AMOUNT OF TIME AND ARE USED IN CLINICAL TRIALS TO MEASURE WHETHER A DRUG IS ALTERING THE COURSE OF THE DISEASE. - BIOMARKERS: ANYTHING THAT CAN BE USED AS AN INDICATOR OF A PARTICULAR DISEASE STATE - USUALLY PROTEINS, ENZYMES, GENETIC VARIANTS, IMAGING (MRI, CT OR PET SCANS). BIOMARKERS CAN BE USED TO ASSESS RISK OF DISEASE, DIAGNOSIS, OR OUTCOMES. USE OF BIOMARKERS IN DRUG DEVELOPMENT IS OF GREAT INTEREST BECAUSE BIOMARKERS CAN PROVIDE EVIDENCE OF BIOLOGICAL ACTIVITY, POTENTIALLY DEMONSTRATING THERAPEUTIC BENEFIT MORE QUICKLY THAN TRADITIONAL OUTCOME MEASURES. - BIOREPOSITORY: A REPOSITORY OR BANK OF STORED BIOLOGICAL MATERIALS SUCH AS BLOOD SAMPLES, DNA, ORGANS, AND TISSUES (SUCH AS SKIN, MUSCLE, HEART) THAT CAN BE USED FOR RESEARCH.THROUGH THE CCRN IN FA WE HAVE COLLECTED SIX YEARS OF NATURAL HISTORY DATA (ONGOING) IN MORE THAN 650 INDIVIDUALS WITH FA, VALIDATED CLINICAL OUTCOME MEASURES AND THE FARS SCALE, STUDIED SPEECH, VISION AND HEARING, LAUNCHED BIOMARKER STUDIES, ESTABLISHED DNA AND RNA REPOSITORIES, AND PROVIDED MANY BLOOD SAMPLES TO RESEARCHERS AROUND THE WORLD. THE CCRN IN FA INVESTIGATORS HAVE BEEN INVOLVED IN MULTIPLE CLINICAL TRIALS INCLUDING A FEW THAT WERE DESIGNED AND CONDUCTED SOLELY THROUGH NETWORK SITES.FARA CONTRIBUTED MORE THAN $550,000 IN 2012 TO CLINICAL RESEARCH INFRASTRUCTURE IN DIRECT FUNDING TO THE CCRN IN FA CENTERS AND RELATED CLINICAL RESEARCH ACTIVITIES.TITLES AND SUMMARIES OF MOST OF THE PROJECTS PRESENTLY FUNDED BY FARA ARE AVAILABLE AT:WWW.CUREFA.ORG/RPMP/PUBLIC/PGGRANTLIST.ASPX AND COMPLETE LISTINGS OF GRANTS AWARDED BY YEAR CAN BE ACCESSED AT: WWW.CUREFA.ORG/GRANTS-AWARDED.HTMLDescription

Activity2 Activity2

FieldValueIRS element (for citing)
Expense71283Expense
DescriptionRESEARCH CONFERENCES: FARA ORGANIZES AND SUPPORTS A NUMBER OF SCIENTIFIC CONFERENCES TO IMPROVE SHARING OF KNOWLEDGE, INSIGHTS AND ADVANCES AND BUILD COLLABORATIONS AND SYNERGISTIC CONNECTIONS BETWEEN FA RESEARCHERS. FARA ORGANIZED A CONFERENCE IN MAY 2012 IN PHILADELPHIA, TO BRING FA SCIENTISTS FROM AROUND THE WORLD WHO ARE WORKING ON MOUSE MODELS, INDUCED PLURIPOTENT STEM CELL (IPS) MODELS OF FA, AND GENE THERAPY APPROACHES. RESEARCHERS PRESENTED THEIR LATEST DATA (NOT YET PUBLISHED OR PUBLICLY AVAILABLE) TO HELP ADDRESS GAPS IN THE CURRENT MODELS AND SHARE NEW DISCOVERIES AND TECHNOLOGIES.DR. CAT LUTZ FROM JAX LABS REPORTED ON A SIGNIFICANT BREAKTHROUGH IN A COLLABORATIVE PROJECT, FUNDED BY FARA, TO PRODUCE EXTENSIVE CHARACTERIZATION OF SEVERAL DIFFERENT FA MOUSE MODELS. THEY IDENTIFIED A REPRODUCIBLE AND MEASURABLE ATAXIA (SIMILAR TO WHAT WE SEE IN INDIVIDUALS WITH FA) IN ONE OF THE MODELS. THIS IS SIGNIFICANT BECAUSE IT GIVES US AN ANIMAL MODEL FOR TESTING THE EFFECTS OF VARIOUS DRUGS ON THE NEUROLOGIC PHENOTYPE IN FA. SEVERAL OTHER INVESTIGATORS REPORTED ON ONGOING EFFORTS TO CONTINUE TO IMPROVE UPON THESE MODELS. FOR EXAMPLE, THE CURRENT MOUSE MODELS ARE STILL RELATIVELY MILD COMPARED TO HUMANS (SYMPTOMS ARE MILD AND SLOW TO APPEAR) - IF NEWER MODELS HAD LOWER LEVELS OF FRATAXIN OR MORE CARDIAC SYMPTOMS, AND SHOWED SYMPTOMS EARLIER IN LIFE, OUR ABILITY TO SCREEN DRUG CANDIDATES WOULD BE ENHANCED.THREE DIFFERENT RESEARCH GROUPS PRESENTED ON UNIQUE APPROACHES TO GENE THERAPY FOR FA. EACH GROUP IS EVALUATING DIFFERENT APPROACHES OF DELIVERY TO GIVE INDIVIDUALS WITH FA A FULLY FUNCTIONAL COPY OF THE FRATAXIN GENE. DR. HELENE PUCCIO SHARED VERY ENCOURAGING DATA THAT SHOWED HOW SHE WAS ABLE TO RESCUE A SEVERE FORM OF CARDIOMYOPATHY IN AN FA MOUSE WITH FRATAXIN "KNOCKED-OUT" IN THE HEART.Description

Activity3 Activity3

FieldValueIRS element (for citing)
Expense146242Expense
DescriptionEDUCATION, AWARENESS & OUTREACH PROGRAMS: FRIEDREICH'S ATAXIA (FA) IS A RARE DISEASE; AFFECTING 1 IN 50,000 INDIVIDUALS. FARA IS DEDICATED TO RAISING AWARENESS FOR FA. FARA HAS UTILIZED BOTH TRADITIONAL AND SOCIAL MEDIA STRATEGIES TO BRING GREATER AWARENESS TO FA IN THE GENERAL PUBLIC AND TO ENGAGE AND EDUCATE THE FA COMMUNITY. IN 2012, FARA WAS ABLE TO PARTNER WITH SEVERAL CELEBRITIES TO CREATE VIDEO-BASED AWARENESS CAMPAIGNS LEVERAGED THROUGH SOCIAL MEDIA.JAMES BLAKE-JAMES BLAKE & KYLE BRYANT- CONFIDENCE IN FA RESEARCHHTTP://WWW.YOUTUBE.COM/WATCH?V=GAF2MU4PQCYJAMES BLAKE-JAMES & THOMAS BLAKE- OVERCOMING ADVERSITYHTTP://WWW.YOUTUBE.COM/WATCH?V=5-ILHACOIRKJOHN ISNER - JOHN ISNER & KYLE BRYANT DISCUSS THE VALUE OF DETERMINATION & PERSEVERANCE - HTTP://WWW.YOUTUBE.COM/WATCH?V=5P7B31BUK18EDUCATIONAL SYMPOSIAFARA CO-ORGANIZED TWO PATIENT SYMPOSIUMS WITH CLINICAL RESEARCH NETWORK SITES, CHILDREN'S HOSPITAL OF PHILADELPHIA (CHOP) AND UNIVERSITY OF SOUTH FLORIDA (USF). THE CHOP AND FARA TEAM LED AN ALL-DAY SYMPOSIUM AT IN KING OF PRUSSIA, PA ON OCTOBER 8TH, 2012. THERE WERE MORE THAN 150 PATIENT FAMILIES WHO PARTICIPATED. THE SYMPOSIUM PROVIDED: - CLINICAL UPDATES, INCLUDING CARDIOLOGY, NEUROLOGY, PHYSICAL THERAPY, AND PREGNANCY IN PATIENTS WITH FA; - UPDATES ON CURRENT RESEARCH AND CLINICAL TRIALS, INCLUDING GENE THERAPY, HDAC INHIBITORS AND - PANEL DISCUSSION ON ACCESSIBLE TRAVEL.THE SYMPOSIUM AT USF HAD ABOUT 200 ATTEND AND WAS STREAMED LIVE ON FACEBOOK AND THERE WERE NEARLY 1000 VIEWS. THE USF SYMPOSIUM FOCUSED ON CARDIAC ASPECTS OF FA, ADVANCES IN GENE THERAPY AND THE ANNOUNCEMENT OF A CLINICAL TRIAL OF DRUG TARGETING MITOCHONDRIAL DYSFUNCTION IN FA.AMBASSADOR PROGRAMALSO, IN 2011 FARA LAUNCHED A NEW AMBASSADOR PROGRAM WHICH MENTORS AND ENCOURAGES INDIVIDUALS WITH FA TO DEVELOP AND SHARE THEIR PERSONAL STORY AND TO BEGIN GRASSROOTS OUTREACH TO RAISE AWARENESS. IN 2012, THE GROUP GREW TO >15 PARTICIPANTS. MANY OF THEM SHARED THEIR STORIES AT FUNDRAISING EVENTS, COMMUNITY GROUPS AND/OR WITH THE MEDIA.ATAXIAN ATHLETE INITIATIVE (AAI)AAI IS A GRANT PROGRAM THAT PROVIDES, THROUGH A COMPETITIVE GRANT APPLICATION PROCESS, FUNDING FOR EQUIPMENT THAT ENABLES ELIGIBLE INDIVIDUALS WITH ATAXIA WHO HAVE DEMONSTRATED THE DESIRE TO STAY ACTIVE AND HEALTHY DESPITE THEIR DISABILITIES, TO START OR FURTHER DEVELOP THEIR ABILITIES IN ADAPTIVE CYCLING. TO QUALIFY, APPLICANTS MUST HAVE BEEN DIAGNOSED WITH SOME FORM OF ATAXIA. APPLICANTS ARE REQUIRED TO SUBMIT AN ESSAY SUMMARIZING THEIR EXPERIENCE WITH ATAXIA AND THEIR EFFORTS TO STAY ACTIVE. ALL APPLICATIONS ARE REVIEWED BY A PANEL OF DISABLED ATHLETES, ATAXIANS, AND OTHER REPRESENTATIVES OF THE ATAXIA COMMUNITY. GRANTS WILL WERE AWARDED TO A LIMITED NUMBER OF APPLICANTS BASED ON THE FOLLOWING: - DIAGNOSIS - APPLICANTS MUST HAVE BEEN DIAGNOSED WITH SOME FORM OF ATAXIA TO QUALIFY; - APPLICANT'S PERCEIVED CHARACTER, DRIVE, AND COMMITMENT TO AN ACTIVE LIFESTYLE; - FINANCIAL NEED AND - DETAILED RESEARCH AND KNOWLEDGE OF EQUIPMENT REQUESTED.IN 2012, FARA AWARDED PARTIAL FUNDING FOR ADAPTIVE CYCLING EQUIPMENT TO SEVEN PEOPLE LIVING WITH ATAXIA.Description
FieldValueIRS element (for citing)
Total Program Service Expense3052607TotalProgramServiceExpense
Described In501 C31DescribedIn501C3
Schedule B Required1ScheduleBRequired
Political Activities0PoliticalActivities
Lobbying Activities1LobbyingActivities
Subject To Proxy Tax0SubjectToProxyTax
Donor Advised Funds0DonorAdvisedFunds
Conservation Easements0ConservationEasements
Collections Of Art0CollectionsOfArt
Credit Counseling0CreditCounseling
Term Or Permanent Endowments0TermOrPermanentEndowments
Report Land Bldg Equip1ReportLandBldgEquip
Report Invest Oth Securities0ReportInvestOthSecurities
Report Prog Rel Invest1ReportProgRelInvest
Report Other Assets0ReportOtherAssets
Report Other Liabilities0ReportOtherLiabilities
Report Fin48 Footnote1ReportFin48Footnote
Independent Audit Financial Stmt1IndependentAuditFinancialStmt
Consolidated Audit Financial Stmt0ConsolidatedAuditFinancialStmt
School0School
Foreign Office0ForeignOffice
Foreign Activities1ForeignActivities
More Than5000 K To Organizations1MoreThan5000KToOrganizations
More Than5000 K To Individuals0MoreThan5000KToIndividuals
Professional Fundraising0ProfessionalFundraising
Fundraising Activities1FundraisingActivities
Gaming0Gaming
Hospital0Hospital
Grants To Organizations1GrantsToOrganizations
Grants To Individuals0GrantsToIndividuals
Schedule J Required1ScheduleJRequired
Tax Exempt Bonds0TaxExemptBonds
Excess Benefit Transaction0ExcessBenefitTransaction
Prior Excess Benefit Transaction0PriorExcessBenefitTransaction
Loan To Officer Or DQP0LoanToOfficerOrDQP
Grant To Related Person0GrantToRelatedPerson
Bsnss Rltnshp With Organization0BsnssRltnshpWithOrganization
Bsnss Rltnshp Thru Family Member0BsnssRltnshpThruFamilyMember
Officer Entity With Bsnss Rltnshp0OfficerEntityWithBsnssRltnshp
Deductible Non Cash Contributions1DeductibleNonCashContributions
Deductible Contributions Of Art0DeductibleContributionsOfArt
Terminated0Terminated
Partial Liquidation0PartialLiquidation
Disregarded Entity0DisregardedEntity
Related Entity0RelatedEntity
Related Org Controlled Entity0RelatedOrgControlledEntity
Transfers To Exempt Non Chrtbl Org0TransfersToExemptNonChrtblOrg
Activities Conducted Partnership0ActivitiesConductedPartnership
Schedule O Required1ScheduleORequired
Number Forms Transmitted With10962NumberFormsTransmittedWith1096
Number W2 G Included0NumberW2GIncluded
Compliance With Backup Witholding1ComplianceWithBackupWitholding
Number Of Employees6NumberOfEmployees
Employment Tax Returns Filed1EmploymentTaxReturnsFiled
Unrelated Business Income0UnrelatedBusinessIncome
Foreign Financial Account0ForeignFinancialAccount
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTrans
Taxable Party Notification0TaxablePartyNotification
Non Deductible Contributions0NonDeductibleContributions
Quid Pro Quo Contributions1QuidProQuoContributions
Quid Pro Quo Disclosure1QuidProQuoDisclosure
Form8282 Property Disposed Of0Form8282PropertyDisposedOf
Funds To Pay Premiums0FundsToPayPremiums
Premiums Paid0PremiumsPaid
Indoor Tanning Services0IndoorTanningServices
Info In Schedule O Part VIXInfoInScheduleOPartVI
Nbr Voting Governing Body Members16NbrVotingGoverningBodyMembers
Number Independent Voting Members15NumberIndependentVotingMembers
Family Or Business Relationship0FamilyOrBusinessRelationship
Delegation Of Management Duties0DelegationOfManagementDuties
Changes To Organizing Docs0ChangesToOrganizingDocs
Material Diversion Or Misuse0MaterialDiversionOrMisuse
Members Or Stockholders0MembersOrStockholders
Election Of Board Members0ElectionOfBoardMembers
Decisions Subject To Approval0DecisionsSubjectToApproval
Minutes Of Governing Body1MinutesOfGoverningBody
Minutes Of Committees1MinutesOfCommittees
Officer Mailing Address0OfficerMailingAddress
Local Chapters0LocalChapters
Form990 Provided To Governing Body1Form990ProvidedToGoverningBody
Conflict Of Interest Policy1ConflictOfInterestPolicy
Annual Disclosure Covered Persons1AnnualDisclosureCoveredPersons
Regular Monitoring Enforcement1RegularMonitoringEnforcement
Whistleblower Policy1WhistleblowerPolicy
Document Retention Policy1DocumentRetentionPolicy
Compensation Process CEO1CompensationProcessCEO
Compensation Process Other1CompensationProcessOther
Investment In Joint Venture0InvestmentInJointVenture
States Where Copy Of Return Is FiledALStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledAKStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledAZStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledARStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledCAStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledCOStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledCTStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledFLStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledGAStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledILStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledKSStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledKYStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledMEStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledMDStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledMSStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledMIStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledMNStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledMSStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledMOStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledNHStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledNJStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledNMStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledNYStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledNCStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledNDStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledOHStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledOKStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledORStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledPAStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledRIStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledSCStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledTNStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledUTStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledVAStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledWAStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledWVStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledWIStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledMAStatesWhereCopyOfReturnIsFiled
Own WebsiteXOwnWebsite
Other WebsiteXOtherWebsite
Upon RequestXUponRequest

The Books Are In Care Of TheBooksAreInCareOf

Name Business NameBusiness

FieldValueIRS element (for citing)
Business Name Line1JENNIFER FARMERBusinessNameLine1
FieldValueIRS element (for citing)
Telephone Number4848796160TelephoneNumber

Address US AddressUS

FieldValueIRS element (for citing)
Address Line1533 W UWCHLAN AVENUEAddressLine1
CityDOWNINGTOWNCity
StatePAState
ZIP Code19335ZIPCode

Form990 Part VII Section A Form990PartVIISectionA (17 entries)

TitleTitleAverage Hours Per WeekAverageHoursPerWeekIndividual Trustee Or DirectorIndividualTrusteeOrDirectorOfficerOfficerHighest Compensated EmployeeHighestCompensatedEmployeeReportable Comp From OrganizationReportableCompFromOrganizationReportable Comp From Related OrgsReportableCompFromRelatedOrgsOther CompensationOtherCompensation
RONALD BARTEK
PRESIDENT/DIRECTOR40.00XXX16000000
EDWARD RAMSEY
CHAIRMAN0.00XX000
MARILYN E DOWNING
SECRETARY0.00XX000
RUTH DEWITT
TREASURER0.00XX000
JENNIFER GOOD
DIRECTOR0.00X000
PAUL AVERY
DIRECTOR0.00X000
PETER CRISP
DIRECTOR0.00X000
THOMAS A DECOTIIS PHD
DIRECTOR0.00X000
DR EARL GILLER
SCIENTIFIC DIRECTOR0.00X000
DR HOLLY HEDRICK
DIRECTOR0.00X000
NICHOLAS A JOHNSON
DIRECTOR0.00X000
LAURA KALICK
DIRECTOR0.00X000
STEVE KLASKO
DIRECTOR0.00X000
BILL ALEFANTIS
DIRECTOR0.00X000
PETER PITTS
DIRECTOR0.00X000
BERNARD RAVINA
SCIENTIFIC DIRECTOR0.00X000
JENNIFER FARMER
EXECUTIVE DIRECTOR40.00X8446000
FieldValueIRS element (for citing)
Total Reportable Comp From Org244460TotalReportableCompFromOrg
Total Reportable Comp Frm Rltd Orgs0TotalReportableCompFrmRltdOrgs
Total Other Compensation0TotalOtherCompensation
Number Individuals GT100 K1NumberIndividualsGT100K
Formers Listed0FormersListed
Total Comp GT150 K1TotalCompGT150K
Compensation From Other Sources0CompensationFromOtherSources
Number Of Contractors GT100 K0NumberOfContractorsGT100K
Fundraising Events2314248FundraisingEvents
All Other Contributions860404AllOtherContributions
Total Contributions3174652TotalContributions

Investment Income InvestmentIncome

FieldValueIRS element (for citing)
Total Revenue Column21555TotalRevenueColumn
Exclusion$21,555ExclusionAmount
FieldValueIRS element (for citing)
Gross Income Fundraising Events650364GrossIncomeFundraisingEvents
Cntrbtns Rprtd Fundraising Events2314248CntrbtnsRprtdFundraisingEvents
Fundraising Direct Expenses522786FundraisingDirectExpenses

Net Income From Fundraising Events NetIncomeFromFundraisingEvents

FieldValueIRS element (for citing)
Total Revenue Column127578TotalRevenueColumn
Exclusion$127,578ExclusionAmount

Total Revenue TotalRevenue

FieldValueIRS element (for citing)
Total Revenue Column3323785TotalRevenueColumn
Related Or Exempt Function Income0RelatedOrExemptFunctionIncome
Unrelated Business Revenue0UnrelatedBusinessRevenue
Exclusion$149,133ExclusionAmount

Grants To Domestic Orgs GrantsToDomesticOrgs

FieldValueIRS element (for citing)
Total1827527Total
Program Services1827527ProgramServices

Foreign Grants ForeignGrants

FieldValueIRS element (for citing)
Total845630Total
Program Services845630ProgramServices

Comp Current Officers Directors CompCurrentOfficersDirectors

FieldValueIRS element (for citing)
Total244460Total
Program Services187568ProgramServices
Management And General16446ManagementAndGeneral
Fundraising40446Fundraising

Other Salaries And Wages OtherSalariesAndWages

FieldValueIRS element (for citing)
Total131557Total
Program Services73674ProgramServices
Management And General6032ManagementAndGeneral
Fundraising51851Fundraising

Other Employee Benefits OtherEmployeeBenefits

FieldValueIRS element (for citing)
Total10752Total
Program Services7470ProgramServices
Management And General643ManagementAndGeneral
Fundraising2639Fundraising

Payroll Taxes PayrollTaxes

FieldValueIRS element (for citing)
Total33524Total
Program Services23291ProgramServices
Management And General2004ManagementAndGeneral
Fundraising8229Fundraising

Fees For Services Legal FeesForServicesLegal

FieldValueIRS element (for citing)
Total1050Total
Fundraising1050Fundraising

Fees For Services Accounting FeesForServicesAccounting

FieldValueIRS element (for citing)
Total9900Total
Management And General9900ManagementAndGeneral

Fees For Services Other FeesForServicesOther

FieldValueIRS element (for citing)
Total7383Total
Program Services1135ProgramServices
Management And General29ManagementAndGeneral
Fundraising6219Fundraising

Advertising Advertising

FieldValueIRS element (for citing)
Total8048Total
Program Services8048ProgramServices

Office Expenses OfficeExpenses

FieldValueIRS element (for citing)
Total18477Total
Program Services10460ProgramServices
Management And General7642ManagementAndGeneral
Fundraising375Fundraising

Travel Travel

FieldValueIRS element (for citing)
Total51715Total
Program Services46502ProgramServices
Management And General3590ManagementAndGeneral
Fundraising1623Fundraising

Conferences Meetings ConferencesMeetings

FieldValueIRS element (for citing)
Total13442Total
Program Services8637ProgramServices
Management And General4805ManagementAndGeneral

Depreciation Depletion DepreciationDepletion

FieldValueIRS element (for citing)
Total779Total
Management And General779ManagementAndGeneral

Insurance Insurance

FieldValueIRS element (for citing)
Total3333Total
Management And General3333ManagementAndGeneral

Other Expenses OtherExpenses (4 entries)

DescriptionDescriptionTotalTotalProgram ServicesProgramServicesManagement And GeneralManagementAndGeneralFundraisingFundraising
BOOKS, SUBSCRIPTIONS &25241169792822616
FACILITIES AND EQUIPMEN19299965024127237
BUSINESS REGISTRATION F4315900253390
CREDIT CARD & BANK FEES3733402753418

All Other Expenses AllOtherExpenses

FieldValueIRS element (for citing)
Total1047Total
Program Services378ProgramServices
Management And General239ManagementAndGeneral
Fundraising430Fundraising

Total Functional Expenses TotalFunctionalExpenses

FieldValueIRS element (for citing)
Total3261212Total
Program Services3052607ProgramServices
Management And General59082ManagementAndGeneral
Fundraising149523Fundraising

Cash Non Interest Bearing CashNonInterestBearing

FieldValueIRS element (for citing)
BOY287214BOY
EOY511067EOY

Savings And Temp Cash Investments SavingsAndTempCashInvestments

FieldValueIRS element (for citing)
BOY687079BOY
EOY726101EOY

Accounts Receivable AccountsReceivable

FieldValueIRS element (for citing)
BOY124538BOY
EOY77128EOY

Prepaid Expenses Deferred Charges PrepaidExpensesDeferredCharges

FieldValueIRS element (for citing)
BOY5144BOY
EOY8551EOY
FieldValueIRS element (for citing)
Land Buildings Equipment Basis4631LandBuildingsEquipmentBasis
Land Bldg Equipment Accum Deprec2779LandBldgEquipmentAccumDeprec

Land Buildings Equipment Basis Net LandBuildingsEquipmentBasisNet

FieldValueIRS element (for citing)
BOY1794BOY
EOY1852EOY

Investments Pub Traded Securities InvestmentsPubTradedSecurities

FieldValueIRS element (for citing)
BOY577989BOY
EOY607771EOY

Investments Program Related InvestmentsProgramRelated

FieldValueIRS element (for citing)
BOY1100000BOY
EOY1100000EOY

Total Assets TotalAssets

FieldValueIRS element (for citing)
BOY2783758BOY
EOY3032470EOY

Accounts Payable Accrued Expenses AccountsPayableAccruedExpenses

FieldValueIRS element (for citing)
BOY170510BOY
EOY264360EOY

Total Liabilities TotalLiabilities

FieldValueIRS element (for citing)
BOY170510BOY
EOY264360EOY
FieldValueIRS element (for citing)
Follow SFAS117XFollowSFAS117

Unrestricted Net Assets UnrestrictedNetAssets

FieldValueIRS element (for citing)
BOY2468579BOY
EOY2572398EOY

Temporarily Restricted Net Assets TemporarilyRestrictedNetAssets

FieldValueIRS element (for citing)
BOY144669BOY
EOY195712EOY

Total Net Assets Fund Balances TotalNetAssetsFundBalances

FieldValueIRS element (for citing)
BOY2613248BOY
EOY2768110EOY

Total Liab Net Assets Fund Balances TotalLiabNetAssetsFundBalances

FieldValueIRS element (for citing)
BOY2783758BOY
EOY3032470EOY
FieldValueIRS element (for citing)
Info In Schedule O Part XIXInfoInScheduleOPartXI
Reconcilation Revenue Expenses62573ReconcilationRevenueExpenses
Reconciliation Unrealized Invest39773ReconciliationUnrealizedInvest
Reconcilation Other Changes52516ReconcilationOtherChanges
Info In Schedule O Part XIIXInfoInScheduleOPartXII
Method Of Accounting AccrualXMethodOfAccountingAccrual
Accountant Compile Or Review0AccountantCompileOrReview
FS Audited1FSAudited

FS Audited Basis FSAuditedBasis

FieldValueIRS element (for citing)
Financial Statement SeparateXFinancialStatementSeparate
FieldValueIRS element (for citing)
Audit Committee1AuditCommittee
Federal Grant Audit Required0FederalGrantAuditRequired

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Publicly Supported Org170b1 AviXPubliclySupportedOrg170b1Avi

Gifts Grants Contrib Received170 GiftsGrantsContribReceived170

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years1929438CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years3433440CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years2980429CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year2831171CurrentTaxYearMinus1Year
Current Tax Year3174652CurrentTaxYear
Total14349130Total

Total170 Total170

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years1929438CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years3433440CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years2980429CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year2831171CurrentTaxYearMinus1Year
Current Tax Year3174652CurrentTaxYear
Total14349130Total
FieldValueIRS element (for citing)
Amounts Subst Contributors Total1182492AmountsSubstContributorsTotal
Public Support Total17013166638PublicSupportTotal170

Gross Investment Income170 GrossInvestmentIncome170

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years25162CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years4041CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years57570CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year12704CurrentTaxYearMinus1Year
Current Tax Year21555CurrentTaxYear
Total121032Total
FieldValueIRS element (for citing)
Total Support14470162TotalSupport
Gross Receipts From Admissions Etc25809GrossReceiptsFromAdmissionsEtc
Public Support Pertcentage1700.90990PublicSupportPertcentage170
Public Support Pertcent Prior Year0.89220PublicSupportPertcentPriorYear
Thirty Three Percnt Tests CY170XThirtyThreePercntTestsCY170

Schedule B IRS990ScheduleB

Contributor Info ContributorInfo

FieldValueIRS element (for citing)
Contributor NumberRESTRICTEDContributorNumber

Contributor Name Business ContributorNameBusiness

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor Address US ContributorAddressUS

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Aggregate ContributionsRESTRICTEDAggregateContributions

Schedule C IRS990ScheduleC

FieldValueIRS element (for citing)
Amt Of4955 Tax0AmtOf4955Tax
Amt Of4955 Tax On Managers0AmtOf4955TaxOnManagers

Total Grassroots Lobbying TotalGrassrootsLobbying

FieldValueIRS element (for citing)
Filing Organizations Totals5100FilingOrganizationsTotals

Total Direct Lobbying TotalDirectLobbying

FieldValueIRS element (for citing)
Filing Organizations Totals4000FilingOrganizationsTotals

Total Lobbying Expenditures TotalLobbyingExpenditures

FieldValueIRS element (for citing)
Filing Organizations Totals9100FilingOrganizationsTotals

Other Exempt Purpose Expenditures OtherExemptPurposeExpenditures

FieldValueIRS element (for citing)
Filing Organizations Totals3043507FilingOrganizationsTotals

Total Exempt Purpose Expenditures TotalExemptPurposeExpenditures

FieldValueIRS element (for citing)
Filing Organizations Totals3052607FilingOrganizationsTotals

Lobbying Nontaxable LobbyingNontaxableAmount

FieldValueIRS element (for citing)
Filing Organizations Totals302630FilingOrganizationsTotals

Grassroots Nontaxable GrassrootsNontaxableAmount

FieldValueIRS element (for citing)
Filing Organizations Totals75658FilingOrganizationsTotals

Tot Lobbying Grassroot Minus Non Tx TotLobbyingGrassrootMinusNonTx

FieldValueIRS element (for citing)
Filing Organizations Totals0FilingOrganizationsTotals

Tot Lobby Expend Mns Lobbying Nontx TotLobbyExpendMnsLobbyingNontx

FieldValueIRS element (for citing)
Filing Organizations Totals0FilingOrganizationsTotals

Lobbying Nontaxable Amount2 LobbyingNontaxableAmount2

FieldValueIRS element (for citing)
Current Year302630CurrentYear
Total302630Total
FieldValueIRS element (for citing)
Lobbying Ceiling$453,945LobbyingCeilingAmount

Total Lobbying Expenditures2 TotalLobbyingExpenditures2

FieldValueIRS element (for citing)
Current Year9100CurrentYear
Total9100Total

Grassroots Nontaxable Amount2 GrassrootsNontaxableAmount2

FieldValueIRS element (for citing)
Current Year75658CurrentYear
Total75658Total
FieldValueIRS element (for citing)
Grassroots Ceiling$113,487GrassrootsCeilingAmount

Grassroots Lobbying Expenditures GrassrootsLobbyingExpenditures

FieldValueIRS element (for citing)
Current Year Minus2200CurrentYearMinus2
Current Year Minus13564CurrentYearMinus1
Current Year5100CurrentYear
Total8864Total

Schedule D IRS990ScheduleD

Other Land Buildings OtherLandBuildings

FieldValueIRS element (for citing)
Other Cost Or Other Basis4631OtherCostOrOtherBasis
Depreciation2779Depreciation
Book Value1852BookValue
FieldValueIRS element (for citing)
Total Of Book Value Land Buildings1852TotalOfBookValueLandBuildings

Investments Program Related InvestmentsProgramRelated

FieldValueIRS element (for citing)
DescriptionINVESTMENT IN EDISON PHARMACEUTICALS, INC.Description
Book Value1100000BookValue
Method Of ValuationCMethodOfValuation
FieldValueIRS element (for citing)
Total Of Book Value Program Related1100000TotalOfBookValueProgramRelated
Footnote In Part XIIIXFootnoteInPartXIII
Tot Revenue Etc Audited Fincl Stmt3886344TotRevenueEtcAuditedFinclStmt
Net Unrealized Gains Investments39773NetUnrealizedGainsInvestments
Other Revenues522786OtherRevenues
Revenue Not Rptd F990562559RevenueNotRptdF990
Revenue Subtotal3323785RevenueSubtotal
Revenue Not Rptd On Fin Stmt0RevenueNotRptdOnFinStmt
Total Revenue Per Form9903323785TotalRevenuePerForm990
Tot Expenses Etc Audited Fincl Stmt3731482TotExpensesEtcAuditedFinclStmt
Other Expenses Included522786OtherExpensesIncluded
Expenses Not Rptd F990522786ExpensesNotRptdF990
Expenses Subtotal3208696ExpensesSubtotal
Other Expenses Not Included52516OtherExpensesNotIncluded
Expenses Not Rptd On Fin Stmt52516ExpensesNotRptdOnFinStmt
Total Expenses Per Form9903261212TotalExpensesPerForm990

Form990 Schedule D Part XIII Form990ScheduleDPartXIII (4 entries)

IdentifierIdentifierReturn ReferenceReturnReferenceExplanationExplanation
DESCRIPTION OF UNCERTAIN TAX POSITIONS UNDER FIN 48:PART X, LINE 2:FARA BELIEVES IT HAS APPROPRIATE SUPPORT FOR ANY TAX POSITIONS TAKEN AND, AS SUCH, DOES NOT HAVE ANY UNCERTAIN TAX POSITIONS THAT ARE MATERIAL TO THE FINANCIAL STATEMENTS. FARA'S FEDERAL RETURN OF ORGANIZATION EXEMPT FROM INCOME TAX (FORM 990) FOR TAX YEARS 2009, 2010 AND 2011 IS SUBJECT TO EXAMINATION BY THE IRS, GENERALLY FOR THREE YEARS AFTER THE TAX RETURNS WERE FILED.
PART XI, LINE 2D - OTHER ADJUSTMENTS:SPECIAL EVENTS EXPENSE
PART XII, LINE 2D - OTHER ADJUSTMENTS:SPECIAL EVENTS EXPENSE
PART XII, LINE 4B - OTHER ADJUSTMENTS:RETURNED GRANT FUNDS ADJUSTMENT

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records Maintained0GrantRecordsMaintained

Accts Actvs Out US Table AcctsActvsOutUSTable (2 entries)

RegionRegionNumber Of OfficesNumberOfOfficesNumber Of EmployeesNumberOfEmployeesType Of Activities ConductedTypeOfActivitiesConductedSpecific Services ProvidedSpecificServicesProvidedTotal ExpendituresTotalExpenditures
EUROPE00GRANTS TO RECIPIENTS LOCATED IN REGIONRESEARCH AND GRANT PROGRAM482135
EAST ASIA AND THE PACIFIC00GRANTS TO RECIPIENTS LOCATED IN REGIONRESEARCH AND GRANT PROGRAM363495
FieldValueIRS element (for citing)
Subtotal Number Of Offices0SubtotalNumberOfOffices
Subtotal Number Of Employees0SubtotalNumberOfEmployees
Cont Number Of Offices0ContNumberOfOffices
Cont Number Of Employees0ContNumberOfEmployees
Total Number Of Offices0TotalNumberOfOffices
Total Number Of Employees0TotalNumberOfEmployees
Subtotal Amount Spent845630SubtotalAmountSpent
Cont Amount Spent0ContAmountSpent
Total Amount Spent845630TotalAmountSpent

Grants To Orgs Outside US GrantsToOrgsOutsideUS (10 entries)

RegionRegionPurpose Of GrantPurposeOfGrantAmount Of Cash GrantAmountOfCashGrantManner Of Cash DisbursementMannerOfCashDisbursement
EAST ASIA AND THE PACIFICMEDICAL RESEARCH49334WIRE
EUROPEMEDICAL RESEARCH32201WIRE
EUROPEMEDICAL RESEARCH31646WIRE
EAST ASIA AND THE PACIFICMEDICAL RESEARCH179161WIRE
EUROPEMEDICAL RESEARCH84000WIRE
EUROPE54288WIRE
EAST ASIA AND THE PACIFIC135000WIRE
EUROPE100000WIRE
EUROPE75000WIRE
EUROPE105000WIRE
FieldValueIRS element (for citing)
Total Number Of501c3 Orgs10TotalNumberOf501c3Orgs
Total Number Of Other Orgs0TotalNumberOfOtherOrgs
Transfer To Foreign Corp0TransferToForeignCorp
Interest In Foreign Trust0InterestInForeignTrust
Own Foreign Corp0OwnForeignCorp
Passive Foreign Invest Co0PassiveForeignInvestCo
Foreign Partnership0ForeignPartnership
Boycott Countries0BoycottCountries

Schedule G IRS990ScheduleG

Events Information EventsInformation

FieldValueIRS element (for citing)
Name Of Event1FARA ENERGY BALLNameOfEvent1
Gross Receipts Event11406981GrossReceiptsEvent1
Charitable Contributions Event1898729CharitableContributionsEvent1
Gross Revenue Event1508252GrossRevenueEvent1
Other Direct Expenses Event1232836OtherDirectExpensesEvent1
Name Of Event2RIDE ATAXIA PHILADELPHIANameOfEvent2
Gross Receipts Event2177083GrossReceiptsEvent2
Charitable Contributions Event2163133CharitableContributionsEvent2
Gross Revenue Event213950GrossRevenueEvent2
Other Direct Expenses Event220796OtherDirectExpensesEvent2
Gross Receipts Other Events1380548GrossReceiptsOtherEvents
Charitable Contrib Other Events1252386CharitableContribOtherEvents
Gross Revenue Other Events128162GrossRevenueOtherEvents
Other Direct Expenses Other Events269154OtherDirectExpensesOtherEvents
Gross Receipts Total2964612GrossReceiptsTotal
Charitable Contributions Total2314248CharitableContributionsTotal
Gross Revenue Total Events650364GrossRevenueTotalEvents
Other Direct Expenses Total Events522786OtherDirectExpensesTotalEvents
Direct Expense Summary Events522786DirectExpenseSummaryEvents
Net Income Summary127578NetIncomeSummary
FieldValueIRS element (for citing)
Name Of Gaming Rec Keeper PersonFELICIA DEROSANameOfGamingRecKeeperPerson

Address Of Gaming Rec Keeper US AddressOfGamingRecKeeperUS

FieldValueIRS element (for citing)
Address Line1533 W UWCHLAN AVENUEAddressLine1
CityDOWNINGTOWNCity
StatePAState
ZIP Code19335ZIPCode

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Records Maintained1RecordsMaintained

Recipient Table RecipientTable (18 entries)

Address Line1AddressUS/AddressLine1CityAddressUS/CityStateAddressUS/StateZIP CodeAddressUS/ZIPCodeEIN Of RecipientEINOfRecipientIRC SectionIRCSectionAmount Of Cash GrantAmountOfCashGrantPurpose Of GrantPurposeOfGrantAddress Line2AddressUS/AddressLine2
UNIVERSITY OF ROCHESTER
515 HYLAN BUILDING RC BOX 270140ROCHESTERNY14627160743209501(C)(3)112718MEDICAL RESEARCH
UNIVERSITY OF SOUTH FLORIDA FOUNDATION
4202 EAST FOWLER AVENUETAMPAFL33620590879015501(C)(3)224047MEDICAL RESEARCH
CHILDREN'S HOSPITAL OF PHILADELPHIA
34TH ST CIVIC CENTER BLVDPHILADELPHIAPA19104231352166501(C)(3)193513MEDICAL RESEARCH
OHIO STATE UNIVERSITY
333 W 10TH AVECOLUMBUSOH43210316025986501(C)(3)75000MEDICAL RESEARCH
ARIZONA STATE UNIVERSITY
UNIVERSITY DRIVE AND MILL AVENUETEMPEAZ85287860196696501(C)(3)113250MEDICAL RESEARCHTEMPE ARIZ
NATIONAL ATAXIA FOUNDATION
2600 FERNBROOK LANE SUITE 119MINNEAPOLISMN55447410832903501(C)(3)2500MEDICAL RESEARCH
SCRIPPS RESEARCH INSTITUTE
10550 NORTH TORREY PINES ROADLA JOLLACA92037330435954501(C)(3)133658MEDICAL RESEARCHOSP-TPC7
THE JACKSON LABORATORY
600 MAIN STREETBAR HARBORME04609010211513501(C)(3)144265MEDICAL RESEARCH
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA LOS ANGELES
10920 WILSHIRE BLVD 5TH FLOORLOS ANGELESCA90024956006143501(C)(3)261857MEDICAL RESEARCH
EMORY UNIVERSITY
201 DOWMAN DRIVEATLANTAGA30322580566256501(C)(3)17900MEDICAL RESEARCH
STATEGICS
1455 ADAMS DR SUITE 2050MENLO PARKCA94025260305594501(C)(3)158959MEDICAL RESEARCH
UNIVERSITY OF CHICAGO
5801 SOUTH ELLIS AVENUECHICAGOIL60637362177139501(C)(3)10200MEDICAL RESEARCH
UNIVERSITY OF IOWA DEPT OF PEDIATRICS
200 HAWKINS DRIVEIOWA CITYIA52242426004813501(C)(3)9000MEDICAL RESEARCH
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
3451 WALNUT STREET RM P 221PHILADELPHIAPA19104231352685501(C)(3)22747MEDICAL RESEARCHFRANKLIN BLDG
INDIANA UNIVERSITY
1044 WEST WALNUTINDIANAPOLISIN46202356001673501(C)(3)38663MEDICAL RESEARCH
REPLIGEN
41 SEYON STWALTHAMMA02453042729386501(C)(3)196666MEDICAL RESEARCH
UNIVERSITY OF TEXAS MD ANDERSON
1515 HOLCOMBE BLVD UNIT 1676HOUSTONTX77030746001118501(C)(3)107283MEDICAL RESEARCH
UNIVERSITY OF FLORIDA - DEPT OF NEUROLOGY
L3-100 MCKNIGHT BRAIN INSTITUTEGAINESVILLEFL32611596002052501(C)(3)5300MEDICAL RESEARCHNEWELL DRIVE
FieldValueIRS element (for citing)
Total Nbr Of501 C3 And Govt Grants16TotalNbrOf501C3AndGovtGrants
Total Nbr Of Other Organizations18TotalNbrOfOtherOrganizations

Form990 Schedule I Part IV Form990ScheduleIPartIV

FieldValueIRS element (for citing)
IdentifierPROCEDURE FOR MONITORING GRANTS IN THE U.S.:Identifier
Return ReferencePART I, LINE 2:ReturnReference
ExplanationSCHEDULE I, PART I, LINE 2: GRANTS ARE REVIEWED BY INDEPENDENT SCIENTIFIC ADVISORS AND APPROVED BY BOARD.Explanation

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Compensation CommitteeXCompensationCommittee
Severance Payment0SeverancePayment
Supplemental Nonqual Retire Plan0SupplementalNonqualRetirePlan
Equity Based Comp Arrangement0EquityBasedCompArrangement
Comp Based On Revenue Of Filing Org0CompBasedOnRevenueOfFilingOrg
Comp Based On Revenue Related Orgs0CompBasedOnRevenueRelatedOrgs
Comp Based Net Earnings Filing Org0CompBasedNetEarningsFilingOrg
Comp Based Net Earnings Relate Orgs0CompBasedNetEarningsRelateOrgs
Any Non Fixed Payments0AnyNonFixedPayments
Initial Contract Exception0InitialContractException

Form990 Schedule J Part II Form990ScheduleJPartII

FieldValueIRS element (for citing)
Name PersonRONALD BARTEKNamePerson
TitlePRESIDENT/DIRECTORTitle
Base Compensation Filing Org160000BaseCompensationFilingOrg
Comp Based On Related Orgs0CompBasedOnRelatedOrgs
Bonus Filing Org0BonusFilingOrg
Bonus Related Orgs0BonusRelatedOrgs
Other Compensation Filing Org0OtherCompensationFilingOrg
Other Compensation Related Orgs0OtherCompensationRelatedOrgs
Deferred Comp Filing Org0DeferredCompFilingOrg
Deferred Comp Related Orgs0DeferredCompRelatedOrgs
Nontaxable Benefits Filing Org0NontaxableBenefitsFilingOrg
Nontaxable Benefits Related Orgs0NontaxableBenefitsRelatedOrgs
Total Compensation Filing Org160000TotalCompensationFilingOrg
Total Compensation Related Orgs0TotalCompensationRelatedOrgs
Comp Report Prior990 Filing Org0CompReportPrior990FilingOrg
Comp Report Prior990 Related Orgs0CompReportPrior990RelatedOrgs

Schedule M IRS990ScheduleM

Securities Publicly Traded SecuritiesPubliclyTraded

FieldValueIRS element (for citing)
Non Cash CheckboxXNonCashCheckbox
Number Of Contributions3NumberOfContributions
Noncash Contribs Rptd F99055849NoncashContribsRptdF990
Method Of Determining RevenuesMARKET PRICEMethodOfDeterminingRevenues
FieldValueIRS element (for citing)
Any Property That Must Be Held0AnyPropertyThatMustBeHeld
Review Process Unusual NC Gifts0ReviewProcessUnusualNCGifts
Third Parties Used0ThirdPartiesUsed

Schedule O IRS990ScheduleO

General Explanation GeneralExplanation (8 entries)

Return ReferenceReturnReferenceExplanationExplanationIdentifierIdentifier
FORM 990, PART VI, SECTION B, LINE 11COPIES OF 990 ARE DISTRIBUTED TO BOARD MEMBERS FOR REVIEW AND APPROVAL PRIOR TO FILING.
FORM 990, PART VI, SECTION B, LINE 12CALL NEW AND EXISTING BOARD MEMBERS REQUIRED TO ANNUALLY COMPLETE A CONFLICT OF INTEREST STATEMENT
FORM 990, PART VI, SECTION B, LINE 15EVALUATION AND COMPENSATION COMMITTEE PERFORMS EMPLOYEE EVALUATIONS AND DETERMINES SALARY INCREASES ON A YEARLY BASIS FOR ALL EMPLOYEES. COMMITTEE EXAMINES BENCHMARK DATA IN DETERMINING SALARIES FOR PRESIDENT AND EXECUTIVE DIRECTOR.
FORM 990, PART VI, SECTION C, LINE 18FORM 990 IS AVAILABLE ON THE ORGANIZATION'S WEBSITE AS WELL AS GUIDESTAR.ORG AND CHARITYNAVIGATOR.ORG
FORM 990, PART VI, SECTION C, LINE 19FINANCIAL STATEMENTS ARE AVAILABLE ON THE ORGANIZATION'S WEBSITE. THE GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FORM 1023 ARE AVAILABLE UPON REQUEST.
FORM 990, PART VI LINE 17THE ORGANIZATION IS ALSO REGISTERED TO SOLICIT CONTRIBUTIONS IN THE STATES LISTED.
FORM 990, PART XI, LINE 9:RETURNED GRANT FUNDS 52,516.CHANGES IN NET ASSETS OR FUND BALANCES:
FORM 990, PART XII, LINE 2CFARA'S AUDIT COMMITTEE CONSISTS OF THE EXECUTIVE COMMITTEE, EXECUTIVE DIRECTOR AND ONE AT-LARGE BOARD MEMBER. EACH YEAR THE AUDIT COMMITTEE SEEKS THE SERVICES OF AN OUTSIDE ACCOUNTING FIRM AND CONTRACTS FOR A FULL AUDIT, PREPARATION OF FINANCIAL STATEMENTS AND FILING OF THE 990. THE AUDIT COMMITTEE IS RESPONSIBLE FOR REVIEWING RECOMMENDATIONS FROM THE AUDIT AND PROPOSING NEW POLICIES AND PROCEDURES AS NECESSARY. THE AUDIT COMMITTEE ALSO PARTICIPATES IN DETAILED REVIEW OF FINANCIAL STATEMENTS AND 990 PRIOR TO SHARING WITH THE FULL BOARD FOR A VOTE. FARA'S BOARD OF DIRECTORS RECEIVES THE FINANCIAL STATEMENTS AND 990 FOR REVIEW AND VOTES TO APPROVE PRIOR TO PUBLIC FILING.